The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of killer cell immunoglobulin-like receptor (KIR)-ligand interactions to prevent relapse in patients (pts) receiving matched unrelated stem cell transplant (SCT) for acute myeloid leukemia (AML).
 
Hind Rafei
No Relationships to Disclose
 
Marcelo Fernández-Viña
No Relationships to Disclose
 
Yudith Carmazzi
No Relationships to Disclose
 
Brandt Moore
No Relationships to Disclose
 
Dana Willis
No Relationships to Disclose
 
Rafet Basar
No Relationships to Disclose
 
Pinaki Prosad Banerjee
No Relationships to Disclose
 
May Daher
No Relationships to Disclose
 
Chitra Hosing
No Relationships to Disclose
 
Partow Kebriaei
No Relationships to Disclose
 
Issa F. Khouri
No Relationships to Disclose
 
Rohtesh Mehta
No Relationships to Disclose
 
Yago Nieto
No Relationships to Disclose
 
Muzaffar H. Qazilbash
Consulting or Advisory Role - Amgen
Speakers' Bureau - Merck; Sanofi
Research Funding - Amgen; Tesaro
 
Elizabeth J. Shpall
Honoraria - Magenta Therapeutics; Novartis
Consulting or Advisory Role - Adaptimmune; Magenta Therapeutics; Novartis; Velos (I)
Travel, Accommodations, Expenses - Magenta Therapeutics; Novartis
 
Richard E. Champlin
No Relationships to Disclose
 
David Marin
No Relationships to Disclose
 
Katayoun Rezvani
Honoraria - Adicet Bio; EMD Serono; Onkimmune; Onkimmune; Synthorx
Consulting or Advisory Role - Adicet Bio; Formula Pharmaceuticals; Onkimmune
Research Funding - Affimed Therapeutics; CytomX Therapeutics; Pharmacyclics
Patents, Royalties, Other Intellectual Property - Patent on generation of BKV CTLs for the treatment of HC or PML; Patent on generation of CAR NK cells
 
Kai Cao
No Relationships to Disclose